Dr. Reddy's Laboratories quarterly results and financials

Dr. Reddy's Laboratories (DRREDDY)₹1,385+1.09%(9 Nov 2026 close)Pharmaceuticals

Key facts

In the Sep 2026 quarter (consolidated), Dr. Reddy's Laboratories reported sales of ₹8,721 Cr, down 1.4% from Sep 2025, and net profit of ₹914 Cr, down 31.7% year on year. For the year to Mar 2026, sales were ₹33,781 Cr and net profit ₹4,160 Cr.

Sales (Sep 2026): ₹8,721 Cr
Net profit (Sep 2026): ₹914 Cr
Sales (FY Mar 2026): ₹33,781 Cr
Net profit (FY Mar 2026): ₹4,160 Cr
EPS (Sep 2026): ₹11.09
Borrowings (Mar 2026): ₹7,737 Cr

Company filings, consolidated accounts; latest reported quarter Sep 2026

Dr. Reddy's Laboratories quarterly results

₹ crore unless stated; each column is a quarter.

Dr. Reddy's Laboratories Quarterly results
	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Sales	7,253	7,131	7,712	8,055	8,401	8,552	8,584	8,842	8,767	7,564	8,122	8,721
Expenses	5,211	5,279	5,560	5,960	6,109	6,523	6,391	6,819	6,863	7,161	7,243	6,972
Operating Profit	2,015	1,824	2,124	2,068	2,266	1,990	2,167	2,003	1,883	380	857	1,716
OPM %	28.0%	26.0%	28.1%	26.1%	27.1%	23.0%	25.0%	23.1%	22.0%	5.0%	11.0%	20.1%
Other Income	219	202	193	314	154	529	291	331	271	481	356	156
Interest	38.88	58.87	59.85	75.78	81.75	65.82	82.80	90.81	93.73	106	126	125
Depreciation	373	368	380	396	470	454	475	504	520	556	536	526
Profit before tax	1,834	1,610	1,890	1,925	1,881	2,013	1,910	1,751	1,547	201	555	1,232
Tax %	24.0%	18.0%	26.0%	30.0%	25.0%	21.0%	26.0%	23.0%	23.0%	−11.0%	21.0%	26.0%
Net Profit	1,380	1,311	1,392	1,341	1,403	1,587	1,411	1,338	1,189	221	436	914
EPS (Rs)	16.60	15.73	16.74	15.07	16.96	19.12	17.03	16.19	14.53	2.66	5.33	11.09

Dr. Reddy's Laboratories profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Dr. Reddy's Laboratories Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	15,600	14,219	14,319	15,468	17,562	19,081	21,594	24,734	28,080	32,735	33,781	33,174
Expenses	11,975	11,711	11,935	12,271	15,028	15,170	17,781	18,206	20,064	24,071	27,235	28,240
Operating Profit	3,575	2,463	2,344	3,169	2,469	3,862	3,754	6,452	7,901	8,514	6,427	4,837
OPM %	23.0%	17.1%	16.0%	21.0%	14.1%	20.1%	17.0%	26.0%	28.0%	26.0%	19.0%	14.6%
Other Income	296	172	155	382	671	336	556	973	911	1,121	1,374	1,265
Interest	82.76	62.81	78.75	88.75	97.69	96.80	95.80	143	171	282	373	450
Depreciation	937	1,025	1,076	1,133	1,161	1,227	1,163	1,247	1,468	1,701	2,055	2,138
Profit before tax	2,869	1,560	1,355	2,345	1,893	2,894	3,069	6,070	7,223	7,711	5,411	3,534
Tax %	26.0%	19.0%	32.0%	17.0%	−7.0%	32.0%	29.0%	25.0%	23.0%	25.0%	23.0%	—
Exceptional items	59.08	40.06	54.08	100	−4.01	−3.01	72.06	−90.10	66.12	107	189	—
Net Profit	2,130	1,292	947	1,950	2,026	1,951	2,183	4,506	5,581	5,724	4,160	2,760
EPS (Rs)	25.04	15.62	11.43	23.55	24.44	23.53	26.27	54.22	67.01	67.86	50.37	33.61
Dividend payout %	15.9%	25.9%	34.9%	16.9%	20.9%	20.9%	23.0%	14.9%	11.9%	12.0%	16.0%	—

Dr. Reddy's Laboratories balance sheet

₹ crore, at each year end.

Dr. Reddy's Laboratories Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	85.31	85.29	83.32	83.26	83.29	83.27	83.27	83.25	83.29	83.31	83.25	84.33
Reserves	9,747	12,449	12,152	12,456	13,907	15,485	17,519	19,067	23,146	28,090	33,387	37,738
Borrowings	4,314	3,350	4,919	5,069	3,835	2,210	3,031	3,384	1,347	2,000	4,673	7,737
Other Liabilities	4,311	4,426	4,495	4,727	4,579	5,440	5,943	7,183	7,612	8,564	9,844	11,004
Total Liabilities	18,456	20,312	21,650	22,335	22,404	23,218	26,578	29,718	32,189	38,738	47,987	56,563
Fixed Assets	5,381	6,565	6,937	6,971	7,198	6,861	8,213	8,124	9,224	10,428	18,228	22,074
CWIP	529	772	3,325	3,470	2,932	1,535	1,565	1,293	1,030	1,419	2,464	1,460
Investments	2,246	3,828	2,109	2,297	2,583	2,675	2,208	2,612	4,982	4,924	4,045	5,278
Other Assets	10,301	9,148	9,280	9,596	9,691	12,147	14,592	17,689	16,952	21,966	23,250	27,749
Inventories	2,574	2,560	2,858	2,913	3,362	3,510	4,548	5,092	4,873	6,360	7,117	7,658
Trade receivables	4,087	4,112	3,788	4,038	3,971	5,012	4,949	6,660	7,223	8,005	9,008	10,095
Cash & equivalents	1,871	492	386	264	223	205	2,079	2,420	1,731	1,727	2,459	3,350
Total Assets	18,456	20,312	21,650	22,335	22,404	23,218	26,578	29,718	32,189	38,738	47,987	56,563

Dr. Reddy's Laboratories cash flow

₹ crore, for each year.

Dr. Reddy's Laboratories Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	2,521	3,260	2,142	1,801	2,866	2,981	3,565	2,809	5,880	4,541	4,635	5,663
Cash from investing activity	−2,366	−1,608	−1,887	−1,482	−768	−495	−2,252	−2,561	−4,105	−4,030	−5,777	−6,419
Cash from financing activity	−434	−1,703	−369	−444	−2,137	−2,519	−30.05	−242	−2,691	−377	1,893	829
Net cash flow	−281	−47.11	−114	−124	−31.07	−27.06	1,290	3.01	−910	133	751	78.18
Capex	1,530	1,205	1,220	1,102	837	611	1,253	1,902	1,883	2,742	3,434	3,836
Free cash flow	1,008	2,064	926	712	2,247	2,409	2,321	1,237	4,007	1,905	1,326	2,003
CFO / OP %	87.9%	110.9%	109.9%	87.9%	105.9%	149.0%	106.9%	93.9%	107.9%	82.9%	77.9%	108.9%

Dr. Reddy's Laboratories ratios

Working-capital days and returns, by year.

Dr. Reddy's Laboratories Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	101	98	99	105	95	106	96	114	108	106	102	111
Inventory days	249	249	283	264	274	231	274	251	233	284	261	229
Days payable	85	89	105	122	112	101	110	112	109	117	98	92
Cash conversion cycle	265	258	276	247	257	236	260	253	232	272	265	248
Working capital days	26	34	−14	39	65	59	57	61	84	118	69	68
ROCE %	22.0%	19.0%	9.0%	8.0%	13.0%	11.0%	16.0%	14.0%	27.0%	27.0%	23.0%	13.0%

Dr. Reddy's Laboratories: frequently asked questions

What are the latest quarterly results of Dr. Reddy's Laboratories?

For the Sep 2026 quarter, Dr. Reddy's Laboratories reported sales of ₹8,721 Cr, down 1.4% year on year and net profit of ₹914 Cr, down 31.7% year on year. The operating margin was 20.1%.

What is the annual revenue of Dr. Reddy's Laboratories?

Dr. Reddy's Laboratories' sales for the year to Mar 2026 were ₹33,781 Cr; over the last twelve months they were ₹33,174 Cr.

What is the net profit of Dr. Reddy's Laboratories?

Net profit for the year to Mar 2026 was ₹4,160 Cr, and ₹2,760 Cr over the last twelve months. Earnings per share over the same trailing period were ₹33.61.

How much debt does Dr. Reddy's Laboratories have?

Dr. Reddy's Laboratories reported borrowings of ₹7,737 Cr at Mar 2026, against cash and equivalents of ₹3,350 Cr.

What is the free cash flow of Dr. Reddy's Laboratories?

Cash from operations was ₹5,663 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹2,003 Cr.

Loading…